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ABSTRACT
Context: Stentless aortic valve prostheses have excellent hemodynamic profiles, but may be associated with an 
increased postoperative heart block when compared to conventional prostheses. Aims: To assess the effect of 
an alternative subcoronary implantation technique on postoperative complete heart block (CHB) and permanent 
pacemaker implantation (PPI) following aortic valve replacement (AVR) with stentless tissue valves. Settings 
and Design: A total of 130 consecutive patients undergoing AVR with stentless tissue valves by a single surgeon 
were studied retrospectively. Materials and Methods: A stentless tissue valve was implanted into 80 patients 
using the conventional modified subcoronary implantation technique, and 50 patients received a stentless tissue 
valve by an alternative subcoronary technique in which the inflow suture line is raised at the level of right-non 
coronary commissure. Data were collected at the time of hospital discharge and at 6–12 months postoperatively.  
Statistical Analysis Used: Independent samples t-test was used to compare continuous variables, and categorical 
variables were compared with the chi-square test. Results: Use of this new method reduced postoperative CHB 
(4.0% vs. 16.3%, P = 0.033), with fewer patients requiring PPI in the early postoperative period (6.0% vs. 18.8%, P 
= 0.041). Echocardiographic examination showed no differences in the effective orifice area, peak and mean aortic 
valve gradients, or left ventricular mass index between groups. Trivial or mild aortic regurgitation was found in 3.9% 
of patients with the conventional modified technique and 4.0% of patients undergoing the alternative technique, 
during follow-up (P > 0.05). Conclusions: Compared to the conventional subcoronary implantation technique, 
the alternative subcoronary implantation technique reduces the incidence of new CHB and the requirement of PPI 
following AVR with stentless tissue valves while preserving mid-term hemodynamic function.
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INTRODUCTION
Cardiac conduction defects are well-known complications 
of aortic valve surgery. Mechanical trauma to the 
Cardiothoracic Surgery
conduction system is the most common contributing 
factor. Higher degree atrioventricular block (AVB), 
although often reversible, may also necessitate permanent 
pacemaker implantation (PPI). It has been reported that 
the incidence of conduction defects requiring PPI in 
patients who underwent aortic valve replacement (AVR) 
with stented prosthetic valves ranges from 3 to 6%.[1-3] 
However, the need for PPI after AVR with stentless tissue 
valves is not well characterized.
Stentless tissue valve prostheses are most commonly 
implanted using the conventional modified subcoronary 
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implantation technique. In this position, there is a risk 
of placing inflow sutures in the atrioventricular (AV) 
conduction system below the commissure between the 
right and non-coronary cusps [Figure 1a]. We previously 
reported that patients undergoing AVR with stentless 
tissue valves have increased need for PPI in the early 
postoperative period.[4] Therefore, we improved our 
technique for placing the inflow suture line when 
implanting the stentless tissue valve in the subcoronary 
position. We compared the incidence of new PPI 
insertion in patients receiving stentless tissue valves in 
the subcoronary position using two different implantation 
techniques. Additionally, the hemodynamic performance 




All adult patients who underwent AVR with a stentless 
tissue valve (Freestyle® Heart Valve, Medtronic, 
Minneapolis, MN, USA) by a single surgeon between 
January 2001 and June 2009 were considered for 
inclusion in this retrospective study. Exclusion criteria 
were the presence of preoperative PPI or automated 
implantable cardioverter-defibrillator, concomitant 
other valve replacement, aortic root replacement, 
aortic root enlargement procedure or left ventricular 
aneurysmectomy, patients receiving allograft or autograft 
(Ross procedure) valves, previous or concurrent septal 
myectomy and concomitant maze procedure. Based on 
these criteria, we retrospectively reviewed the charts for 
all patients who received stentless tissue valves over the 
course of the study period. Patients were divided into 
two groups according to the implantation technique. 
The conventional modified subcoronary implantation 
technique was used in 80 patients and 50 patients 
underwent AVR using the alternative subcoronary 
implantation technique. Concomitant procedures 
included mitral valve repair and coronary arterial bypass 
grafting. Data collection was completed at the time of 
hospital discharge and at follow-up (97.7% complete 
at 6–12 months postoperatively). Patient records from 
each group were analyzed for clinical characteristics, 
electrocardiograms (ECGs), echocardiographic data, 
indication for surgery, postoperative complications, the 
development of new complete heart block (CHB) and the 
need for PPI in the early postoperative period.
Electrocardiogram
Twelve-lead resting ECGs were recorded on a Hewlett-
Packard electrocardiograph with a 0.05–100 Hz filter 
before and after operation. QRS duration, QT and QTc 
intervals were determined directly by the built-in-computer 
software. Experienced cardiologists performed analysis 
of the ECGs.
Echocardiographic assessment
Echocardiographic assessment included M-mode and 
Doppler studies preoperatively and at 6–12 months 
postoperatively. Left ventricular ejection fraction (LVEF), 
left ventricular wall thickness, peak and mean aortic 
gradients, effective orifice area, and left ventricular 
mass were determined preoperatively and on follow-up 
examination. Prosthetic valve competence was assessed 
on the follow-up echocardiogram.
Figure 1: (a) The conventional modified subcoronary implantation technique. Inflow sutures are placed in a continuous fashion in a horizontal plane 
at the level of the nadir of the attachments of the native aortic valve leaflets to the aortic annulus. (b) The alternative subcoronary implantation 
technique. The inflow suture line is elevated at the right-non coronary commissure to minimize the risk of injuring the conduction system
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Surgical techniques
All operations were performed under standard 
cardiopulmonary bypass. Myocardial protection was 
achieved by direct infusion of cold hyperkalemic blood 
cardioplegia into the coronary ostium. A transverse 
aortotomy provided exposure of aortic valve. After 
excision of the aortic valve and annular debridement, the 
aortic annulus was sized. Stentless valves were inserted in 
the subcoronary position using the conventional modified 
subcoronary technique as previously described[5] (n = 
80) or using our alternative technique (n = 50). In the 
conventional modified subcoronary technique, the inflow 
suture line was constructed using three continuous 4-0 
polypropylene sutures placed below each commissure in 
a horizontal plane based on the level of the nadir of the 
attachments of the native valve leaflets to the aortic valve 
annulus [Figure 1a]. In the alternative technique, the inflow 
suture line was constructed in the same horizontal plane, 
but was raised at the level of right coronary commissure 
to avoid the conduction system [Figure 1b].
Criteria for permanent pacemaker implantation
Patients with symptomatic second-degree AVB or third-
degree AVB persisting more than 7 days postoperatively 
were considered for PPI according to the ACC/AHA/
NASPE 2002 guidelines for the implantation of cardiac 
pacemakers and anti-arrhythmia devices.[6] An attending 
electrophysiologist determined the requirement for PPI.
Statistical analysis
Statistical analysis was performed using SPSS 13 for windows 
(SPSS Inc., Chicago, IL, USA). Data were expressed as 
mean value ± standard deviation and assumed a normal 
distribution for continuous variables and as numbers with 
percentage for categorical variables. Independent samples 
t-test was used to compare continuous variables, and the 
chi-square test was used to compare categorical variables. 
Results were assessed with a 95% confidential interval 
(CI) and P values <0.05 were considered to be significant.
Our institutional Health Research Ethics Board approved 
the study protocol and waived the requirement for 
individual patient consent. The authors had full access 
to the data and took responsibility for their integrity. All 
authors have read and agreed to the manuscript as written.
RESULTS
The clinical characteristics of the study patients are 
summarized in Table 1 which outlines the clinical 
demographics of the two groups. Patients in both groups 
were homogenous with respect to age, gender, concomitant 
disease, preoperative diagnosis, left ventricular function, 
ECG and echocardiography characteristics.
Relevant operative and postoperative data are detailed 
in Table 2. There were three perioperative deaths, two 
patients (2.5%) in the conventional group and one patient 
(2.0%) in the alternative group (P > 0.05). No differences 
in the incidence or type of concomitant operation and 
postoperative events were identified between groups. 
Aortic cross-clamp times were similar with both surgical 
techniques (P > 0.05).
Use of the alternative subcoronary implantation technique 
dramatically reduced the development of CHB in the early 
postoperative period compared to patients who underwent 
conventional stentless aortic valve implantation (4.0% vs. 
16.3%, P = 0.033). This reduction in CHB translated into 
a reduced need for PPI in the alternative implantation 
technique group (6.0% vs. 18.8%, P = 0.041).
Echocardiographic parameters were favorable in 
both stentless valve groups. Altering the subcoronary 
implantation technique had no impact on the effective 
orifice area, peak aortic gradient, mean aortic gradient, 
LVEF or left ventricular mass index. No patient in either 
group had clinically significant postoperative aortic 
regurgitation during follow-up. Trivial or mild aortic 
regurgitation occurred in 2 (4.0%) of patients who had 
stentless tissue valve replacement with the alternative 
subcoronary technique and in 3 (3.8%) patients who 
underwent the conventional technique. On follow-up 
echocardiography, there was no difference in the number 
of patients with aortic insufficiency or patient prosthesis 
mismatch between groups [Table 3].
DISCUSSION
AVR is recommended for patients with symptomatic severe 
aortic valve disease. Debate exists regarding the selection 
of the best valve prosthesis to enhance surgical and long-
term outcomes. As compared to traditional stented tissue 
valves, newer stentless tissue valves have been associated 
with early left ventricular remodeling and improvement 
in left ventricular function while providing superior 
hemodynamics.[7,8]
AV conduction disturbances requiring PPI have been a well-
known complication of AVR since the introduction of the 
cardiac valve prosthesis in the early 1950s. Injury to the AV 
conduction pathways during AVR by annular decalcification, 49 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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suture placement and pressure on the conduction tissue 
can cause heart block requiring postoperative PPI.[9,10] 
AVB generally results from trauma to the AV node or His 
bundle in the region of the membranous septum and right 
trigone beneath the non-coronary cusp–right coronary 
cusp commissure. PPI is required in approximately 6% 
Table 1: Preoperative clinical and demographic characteristics for patients undergoing stentless aortic valve replacement
Variables Conventional technique (n = 80) Alternative technique (n = 50) P value
Age (years) 70.45 ± 9.28 72.98 ± 9.16 0.132
Male sex 51 (63.8) 37 (74.0) 0.224
Body mass index (kg/m2) 28.13 ± 5.54 28.72 ± 5.41 0.554
Hypertension 57 (71.3) 37 (74.0) 0.733
Diabetes 17 (21.3) 9 (18.0) 0.652
COPD 28 (35.4) 14 (28.0) 0.307
Congestive heart failure 15 (18.8) 10 (20.0) 0.860
Coronary artery disease 36 (45.0) 28 (56.0) 0.222
Previous MI 20 (25.0) 12 (24.0) 0.898
Previous cardiac surgery 2 (2.5) 3 (6.0) 0.313
Aortic stenosis 40 (50.0) 24 (48.0) 0.824
Aortic regurgitation 5 (6.3) 4 (8.0) 0.702
Aortic stenosis + regurgitation 35 (43.8) 22 (44.0) 0.978
Etiology of aortic valve
  Calcification 60 (75.0) 35 (70.0) 0.532
  Endocarditis 3 (3.8) 1 (2.0) 0.578
  Bicuspid 7 (8.8) 9 (18.0) 0.118
 Other 10 (12.5) 5 (10.0) 0.664
Atrial fibrillation 5 (6.3) 4 (8.0) 0.702
Conduction disturbances
  First-degree AV block 10 (12.5) 8 (16.0) 0.574
  LBBB 6 (7.5) 4 (8.0) 0.917
  RBBB 7 (8.8) 5 (10.0) 0.811
Echocardiographic data
  LVEF (%) 54.31 ± 11.16 52.94 ± 10.19 0.482
  LVEF <35% 7 (8.8) 5 (10.0%) 0.811
  Effective orifice area (cm2) 0.88 ± 0.59 0.97 ± 0.69 0.456
  Peak aortic gradient (mmHg) 68.31 ± 32.04 66.29 ± 25.73 0.708
  Mean aortic gradient (mmHg) 39.89 ± 19.31 38.05 ± 15.24 0.566
  LV mass index (g/m2) 127.77 ± 40.52 125.81 ± 33.29 0.775
AV: Atrioventricular; COPD: Chronic obstructive pulmonary disease; LBBB: Left bundle branch block; LVEF: Left ventricular ejection fraction; MI: Myocardial infarction; 
RBBB: Right bundle branch block. Figures in parentheses are in percentage.
Table 2: Operative and postoperative data of patients undergoing stentless aortic valve replacement
Variables Conventional group (n = 80) Alternative group (n = 50) P value
Bypass time (min) 145.61 ± 47.93 147.51 ± 44.93 0.822
Cross-clamp time (min) 111.11 ± 26.36 111.62 ± 31.77 0.921
Prosthetic aortic valve diameter (mm) 23.65 ± 2.06 24.12 ± 2.11 0.211
Prosthetic aortic valve size ≤21 mm 16 (20.0) 9 (18.0) 0.778
Concomitant mitral valve plasty 2 (2.5) 3 (6.0) 0.313
Concomitant CABG 35 (43.8) 23 (46.0) 0.802
Hospital death 2 (2.5) 1 (2.0) 0.853
Postoperative complications
  LOCS 7 (8.8) 6 (12.0) 0.548
  Pulmonary 14 (17.5) 9 (18.0) 0.942
  Renal 7 (8.8) 5 (10.0) 0.811
  Atrial fibrillation 29 (36.3) 16 (32.0) 0.620
  First-degree AVB 1 (1.3) 1 (2.0) 0.735
  LBBB 10 (12.5) 5 (10.0) 0.664
  RBBB 4 (5.0) 1 (2.0) 0.387
  CHB 13 (16.3) 2 (4.0) 0.033
  PPI 15 (18.8) 3 (6.0) 0.041
AVB: Atrioventricular block; CABG: Coronary artery bypass grafting; CHB: Complete heart block; LBBB: Left bundle branch block; LOCS: Low cardiac output syndrome;  
PPI: Permanent pacemaker implantation; RBBB: Right bundle branch block. Figures in parentheses are in percentage.50 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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of patients after isolated AVR and in up to 6.5% of   
patients after AVR with concomitant coronary artery 
bypass.[6-9] Patient-, surgeon- and valve-specific risk factors 
for AVB following AVR have been described. Bicuspid 
aortic valve, annular calcification, hypertension, preexisting 
conduction disturbances, previous myocardial infarction 
and total perfusion time are significant predictors of PPI 
postoperatively.[2,3,11,12] Totaro et al.[13] demonstrated that 
a continuous inflow suture line rather than interrupted 
sutures is associated with postoperative AV conduction 
defects and PPI.[13] Interestingly, it was recently reported 
that the incidence of heart block was strikingly higher in 
patients randomized to aortic root replacement with a 
Freestyle® valve compared to an allograft valve (9% vs. 0%, 
P < 0.01). The authors did not suggest any reasons for this 
finding,[14] but it is possible that the more rigid sewing ring 
on the Freestyle® valve compared to a homograft valve 
exerts more pressure on the conduction tissue. Therefore, 
the Freestyle® valve may necessitate implantation further 
away from the conduction tissue, as we describe herein, 
than is necessary when implanting a homograft valve.
Limited data have been presented describing the 
development of irreversible AVB requiring PPI after 
AVR with stentless tissue valves. Recent studies reported 
the incidence of PPI following stentless tissue valve 
replacement to be as high as 8.3–19%.[15-17] We also 
previously reported that subcoronary stentless AVR is an 
independent predictor of postoperative heart block and the 
requirement for permanent cardiac pacing following AVR.[4]
During stentless valve implantation using the conventional 
modified subcoronary technique, the inflow sutures are 
placed below each commissure so that the suture line 
sits in a horizontal plane at the level of the nadir of 
the attachments of the native aortic valve leaflets to the 
aortic valve annulus. Consequently, the AV conduction 
system is liable to be injured when the inflow suture line is 
constructed beneath right-non commissure. In the current 
series, 16.3% of patients undergoing stentless tissue valve 
implantation by the conventional modified subcoronary 
technique developed CHB in the early postoperative period.
To minimize the risk of trauma to the conduction system, 
we improved the conventional modified subcoronary 
technique by raising the inflow suture line at the level of 
the commissure of the right and non-coronary leaflets. 
Using this alternative subcoronary implantation technique 
reduced the incidence of postoperative CHB and PPI back 
to an incidence in keeping with AVR with conventional 
valves.[12]
When altering the position of the inflow suture line, care 
must be taken to avoid distortion of the prosthetic valve, 
which could adversely impact the hemodynamics and 
competency of the valve. In this series, peak and mean 
gradients were low in the alternative subcoronary technique 
group and were not different from stentless valves 
implanted with the conventional technique. Postoperative 
echocardiography in patients following stentless tissue 
valve replacement using alternative subcoronary technique 
identified 4.0% of patients with trace/mild aortic 
regurgitation; these outcomes are in accordance with 
previous reports[18] for stentless valve implantation. 
Our results suggest that the alternative subcoronary 
implantation technique does not adversely impact the 
hemodynamic performance of stentless tissue valves and 
can provide excellent short-term clinical results. With the 
inflow suture line moved closer to the coronary ostia, care 
must also be taken to avoid compromising coronary flow. 
In this study, no coronary occlusion or myocardial ischemia 
occurred in any patient (data not shown).
As with all retrospective studies, our analysis may be 
subject to inherent bias. To reduce selection bias, all 
patients undergoing AVR by a single surgeon during the 
study period were considered for inclusion in this study. 
Although patients were enrolled consecutively and were 
comparable, they were not randomized. It is also possible 
that learning curve issues or a bias from using historical 
Table 3: Postoperative echocardiographic data of patients during follow-up
Variables Conventional group (n = 78) Alternative group (n = 49) P value
Left ventricular ejection fraction (%) 54.67 ± 10.39 56.33 ± 10.29 0.381
  Effective orifice area (cm2) 1.57 ± 0.42 1.68 ± 0.49 0.161
  Peak aortic gradient (mmHg) 23.32 ± 10.86 20.97 ± 9.94 0.217
  Mean aortic gradient (mmHg) 12.04 ± 5.94 10.64 ± 4.91 0.171
  LV mass index (g/m2) 103.77 ± 40.46 99.61 ± 22.75 0.512
Prosthetic valve regurgitation
 1+ 2 (2.6) 1 (2.0) 0.853
 2+ 1 (1.3) 1 (2.0) 0.735
 3+ 1 (1.3) 0 (0.0) 0.427
Prosthesis–patient mismatch 5 (6.4) 2 (4.1) 0.580
LV: Left ventricular, Figures in parentheses are in percentage.51 Journal of Cardiovascular Disease Research Vol. 3 / No 1
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controls contributed to the differences in PPI between the 
two techniques. However, PPI was evenly distributed across 
patients in all time points throughout patients undergoing 
the conventional modified subcoronary technique and 
PPI rate fell immediately upon switching to the new 
technique. A much larger cohort investigation is required to 
confirm our findings regarding the alternative subcoronary 
implantation technique. Long-term studies are required to 
confirm excellent valve function at greater than 10 years.
Results from this study indicate significantly reduced 
requirement for PPI with the alternative method of 
subcoronary implantation of the stentless tissue valve. No 
adverse effect was determined by altering the position of 
the inflow suture line, and short to mid-term hemodynamic 
function of stentless tissue valves inserted using this 
technique remains excellent.
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